The Drugreporter Podcast

As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and István Gábor Takács reflect on decades of activism—and explain why they are now taking their fight to the streets to challenge an increasingly repressive system. Chapters:00:00 Summary02:14...

The global drug control system is under growing pressure, as countries experiment with regulation and long-standing assumptions are being challenged. Martin Jelsma, who is stepping down from the Transnational Institute this year after decades of work, has been at the forefront of these debates. In this interview, we discuss the WHO’s coca review, inter se treaty reform, and what these shifts mean...

Ten years after the 2016 UN General Assembly Special Session on drugs (UNGASS), a new report by the International Drug Policy Consortium takes stock of progress and remaining gaps in global drug policy. We spoke with Marie Nougier about what has changed over the past decade—and what still needs to change.Chapters:00:00 Intro00:35 Your new report looks back at ten years since the UN General...

After 15 years at the helm of the International Drug Policy Consortium, Ann Fordham is stepping down as Executive Director. Under her leadership, IDPC has grown into one of the most influential global networks advocating for drug policies grounded in human rights, public health, and social justice. In this interview, we reflect on IDPC's achievements, ongoing challenges, and what lies ahead.00:00...

Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.Jeremy Rudy is the founder and CEO of the Sabba Collective, an organization working at the intersection of science, policy, and culture to support the safe and sustainable integration of psychedelics into society. At the Psychedelic...

Pavel Bém is a Czech psychiatrist and former mayor of Prague who now serves as National Drug Policy Coordinator. With decades of experience at the intersection of politics and addiction medicine, he has been a key figure in shaping the Czech Republic’s pragmatic, health-oriented approach to drug policy. We spoke with him in Vienna during the 69th session of the Commission on Narcotic Drugs (CND)...

Senator Jeff Steinborn is the sponsor of the Medical Psilocybin Act in New Mexico, a visionary step toward expanding access to psychedelic therapy. In this conversation, filmed at the Psychedelic Science 2025 conference in Denver, he discusses why legislative action was necessary, how to ensure inclusion for marginalized communities, and what benchmarks will define success as New Mexico opens its...

Charlotte James is a medicine woman, educator, and founder of the Psychedelic Liberation training. With Afro-Caribbean and Germanic ancestry, her work weaves together ancestral healing, social justice, embodiment, and plant medicine. In our conversation, she speaks about liberation, informed care, the power of ritual, and how to bring accountability and integrity into psychedelic...

Leor Roseman is a psychedelic researcher whose work explores both the individual and collective dimensions of psychedelic experience — from DMT interruption studies to intergroup healing in the Israeli-Palestinian context. In this interview, we discuss how psychedelics may open space not only for personal transformation, but also for collective reconciliation.Drugreporter (EN):...

Jae Sevelius, PhD, is a clinical psychologist and researcher whose work focuses on gender diversity, trauma, and psychedelic healing. Recent studies highlight how psychedelic therapy can bring both gender euphoria and relief from dysphoria for trans and non-binary people. In this conversation, filmed at Psychedelic Science 2025, we explore what truly gender-affirming psychedelic care looks like...